Panbela Therapeutics's market cap is currently $1.55M. The company's EPS TTM is $-32.515; its P/E ratio is ―; Panbela Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -25.65M	$ -35.73M	$ -10.01M	$ -5.75M	$ -4.32M
Operating Income	$ -51.29M	$ -34.09M	$ -10.01M	$ -5.75M	$ -4.32M
EBITDA	$ -51.29M	$ -34.76M	$ -10.61M	$ -5.15M	$ -4.42M
Net Income	$ -25.26M	$ -34.93M	$ -10.13M	$ -4.77M	$ -6.20M
Balance Sheet
Cash & Short-Term Investments	$ 2.58M	$ 1.28M	$ 11.87M	$ 9.02M	$ 2.45M
Total Assets	$ 11.80M	$ 4.98M	$ 12.87M	$ 9.81M	$ 3.14M
Total Debt	$ 5.19M	$ 6.84M	$ 0.00	$ 0.00	$ 116.00K
Net Debt	$ 2.62M	$ 5.56M	$ -11.87M	$ -9.02M	$ -2.33M
Total Liabilities	$ 16.51M	$ 13.03M	$ 2.66M	$ 1.36M	$ 1.76M
Stockholders' Equity	$ -4.71M	$ -8.05M	$ 10.21M	$ 8.45M	$ 1.39M
Cash Flow
Free Cash Flow	$ -25.25M	$ -15.94M	$ -6.70M	$ -3.85M	$ -2.74M
Operating Cash Flow	$ -25.25M	$ -15.28M	$ -6.70M	$ -3.85M	$ -2.74M
Investing Cash Flow	$ 400.00K	$ -656.00K	$ -540.00K	$ 0.00	$ 0.00
Financing Cash Flow	$ 26.14M	$ 5.35M	$ 10.10M	$ 10.44M	$ 3.78M

Currency in USD

Panbela Therapeutics Earnings and Revenue History

Income Statement >

Panbela Therapeutics Debt to Assets

Balance Sheet >

Panbela Therapeutics Cash Flow

Cash Flow >

Panbela Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing